Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ipca.com | |
Market Cap | 23,595.76 Cr. | |
Enterprise Value(EV) | 23,695.60 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 28.40 | Trailing Twelve Months Ending 2022-06 |
Price-Earning Ratio (PE) | 32.75 | Trailing Twelve Months Ending 2022-06 |
Industry PE | 32.02 | Trailing Twelve Months Ending 2022-06 |
Book Value / Share | 222.32 | Trailing Twelve Months Ending 2022-06 |
Price to Book Value | 4.18 | Calculated using Price: 930.05 |
Dividend Yield | 0.43 | Period Ending 2022-03 |
No. of Shares Subscribed | 25.37 Cr. | 253,704,218 Shares |
FaceValue | 1 | |
Company Profile | ||
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India |
1 Day |
|
-0.23% |
1 Week |
|
-8.57% |
1 Month |
|
-6.43% |
3 Month |
|
-5.87% |
6 Month |
|
-5.67% |
1 Year |
|
-23.27% |
2 Year |
|
-8.01% |
5 Year |
|
+344.14% |
10 Year |
|
+360.90% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 27.22 | 12.43 | 4.31 | 8.60 | 9.47 | 15.28 | 18.15 | 27.63 | 17.87 | |
Return on Capital Employed (%) | 27.92 | 13.78 | 4.82 | 9.44 | 9.94 | 16.53 | 19.92 | 30.92 | 20.41 | |
Return on Assets (%) | 16.19 | 7.38 | 2.50 | 5.17 | 6.03 | 10.25 | 12.47 | 20.29 | 13.30 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 1,554 | 1,960 | 2,208 | 2,259 | 2,455 | 2,689 | 3,122 | 3,627 | 4,702 | 5,492 | |
Non Curr. Liab. | 510 | 459 | 700 | 663 | 548 | 419 | 313 | 290 | 190 | 602 | |
Curr. Liab. | 634 | 791 | 904 | 970 | 956 | 1,008 | 1,098 | 1,326 | 1,161 | 1,466 | |
Minority Int. | 16 | 14 | 15 | 77 | |||||||
Equity & Liab. | 2,697 | 3,211 | 3,812 | 3,892 | 3,960 | 4,116 | 4,549 | 5,258 | 6,066 | 7,637 | |
Non Curr. Assets | 1,300 | 1,609 | 2,198 | 2,270 | 2,218 | 2,170 | 2,171 | 2,402 | 2,629 | 3,180 | |
Curr. Assets | 1,397 | 1,601 | 1,614 | 1,622 | 1,742 | 1,945 | 2,378 | 2,856 | 3,437 | 4,457 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,697 | 3,211 | 3,812 | 3,892 | 3,960 | 4,116 | 4,549 | 5,258 | 6,066 | 7,637 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
Net Sales | 3,282 | 3,144 | 2,867 | 3,156 | 3,258 | 3,746 | 4,619 | 5,395 | 5,797 | 5,850 | |
Other Income | 52 | 59 | 41 | 55 | 58 | 75 | 87 | 129 | 122 | 68 | |
Total Income | 3,334 | 3,203 | 2,908 | 3,211 | 3,316 | 3,820 | 4,706 | 5,524 | 5,918 | 5,917 | |
Total Expenditure | -2,570 | -2,630 | -2,593 | -2,741 | -2,816 | -3,067 | -3,729 | -3,914 | -4,539 | -4,688 | |
PBIDT | 764 | 573 | 314 | 470 | 500 | 753 | 977 | 1,610 | 1,379 | 1,230 | |
Interest | -30 | -32 | -35 | -27 | -28 | -22 | -20 | -12 | -11 | -13 | |
Depreciation | -103 | -180 | -163 | -173 | -178 | -182 | -211 | -209 | -232 | -238 | |
Taxation | -152 | -102 | -20 | -68 | -51 | -104 | -135 | -240 | -225 | -228 | |
Exceptional Items | |||||||||||
PAT | 478 | 259 | 96 | 203 | 244 | 444 | 611 | 1,149 | 911 | 750 | |
Minority Interest | 3 | 3 | -1 | -6 | -8 | ||||||
Share Associate | 0 | -5 | -3 | -8 | -4 | -2 | -8 | -8 | -21 | -22 | |
Other Related Items | |||||||||||
Consolidated Net Profit | 479 | 254 | 93 | 195 | 239 | 446 | 606 | 1,140 | 884 | 720 | |
Adjusted EPS | 19 | 10 | 4 | 8 | 9 | 18 | 24 | 45 | 35 | 25 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 389 | 522 | 468 | 709 | 282 | 341 | 501 | 570 | 1,090 | 856 | |
Cash Fr. Inv. | -260 | -369 | -689 | -218 | -149 | -135 | -165 | -510 | -521 | -855 | |
Cash Fr. Finan. | -83 | -136 | 251 | -462 | -159 | -130 | -183 | -137 | -306 | 427 | |
Net Change | 46 | 17 | 29 | 29 | -26 | 75 | 153 | -76 | 264 | 428 | |
Cash & Cash Eqvt | 57 | 74 | 104 | 169 | 143 | 218 | 371 | 295 | 559 | 991 |
Fri, 12 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
|
|
Fri, 12 Aug 2022
Annual General Meeting
|
|
Fri, 12 Aug 2022
Annual General Meeting
|
Fri, 12 Aug 2022 |
|
|
|
|
|